You are here: Industry Insights > SARS-CoV-2

News List

CureVac blames variants for COVID-19 vaccine fail in pivotal trial firstwordpharma
June 17, 2021
CureVac's stock was cut in half on Wednesday after the company reported that its vaccine candidate CVnCoV was only 47% effective at preventing COVID-19 disease of any severity in a second interim analysis, falling short of pre-specified statistical.
Boan Biotech to Start Phase II Clinical Trial in U.S. for Neutralizing Antibody Against SARS-CoV-2 firstwordpharma
June 17, 2021
Luye Pharma Group today announced that its subsidiary Boan Biotech has submitted the investigational new drug (IND) application for a self-developed drug LY-CovMab to the U.S. Food and Drug Administration.
STORM CHASER Trial Fails to Meet Primary Endpoint in Post-Exposure Prevention of Symptomatic COVID-19 americanpharmaceuticalreview
June 17, 2021
AstraZeneca announced results from the STORM CHASER trial assessing the safety and efficacy of AZD7442, a long-acting antibody (LAAB) combination, for the prevention of symptomatic COVID-19 in participants recently exposed to the SARS-CoV-2 virus.
University of Arkansas, NOWDiagnostics Partner for COVID-19 Antibody Test and Prevalence Study prnewswire
June 17, 2021
The University of Arkansas and NOWDiagnostics, Inc., a Springdale-based leader in innovative diagnostics testing, announced today an active partnership to study the prevalence of SARS-CoV-2 virus antibodies among University of Arkansas (U of A) students,
Third Dose of COVID Vaccine Boosts Protection in Transplant Recipients drugs
June 16, 2021
Researchers say an extra dose of two-dose COVID-19 vaccines may improve immune system protection for organ transplant patients, a group that's so far responded poorly to two-dose vaccines.
SARS-CoV-2 Antibodies Identified Before Cases Recognized in U.S. drugs
June 16, 2021
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) antibodies were identified in individuals before the first cases of infection were recognized, according to a study published online June 15 in Clinical Infectious Diseases.
Stop Using Innova SARS-CoV-2 Antigen Rapid Qualitative Test - FDA MedWatch americanpharmaceuticalreview
June 16, 2021
The U.S. FDA issued a safety communication warning the public to stop using the Innova SARS-CoV-2 Antigen Rapid Qualitative Test for diagnostic use.
COVID Rapid Test Confirms Presence of Antibodies prnewswire
June 16, 2021
A U.S. clinical trial of a COVID-19 rapid test approved by an institutional review board found the Specificity of confirmed negative Covid-19 patients by RT-PCR was 100% (95% CI, 88.4%-100.0%).
Nineteen Percent of Asymptomatic COVID-19 Patients Develop Long-Haul COVID prnewswire
June 16, 2021
Nineteen percent of COVID-19 patients without symptoms went on to exhibit at least one of the post-COVID conditions known as long-haul COVID 30 days or more after their initial COVID-19 diagnosis.
BioVaxys Receives Positive FDA Response For Pre-IND Review For CoviDTH Clinical Development prnewswire
June 15, 2021
BioVaxys Technology Corp. is pleased to announce today that FDA has reviewed its Pre-IND request for a Type B review of its CoviDTH program and has determined that a Written Response is sufficient to address the Company's questions regarding

Previous page 1 2 3 4 5 6 7 8 9 10 ... 61 62 Next page